Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat relapsed or refractory multiple myeloma Read more
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management Read more